<?xml version="1.0" encoding="UTF-8"?>
<ref id="B121-microorganisms-08-00085">
 <label>121.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hervás</surname>
    <given-names>J.V.</given-names>
   </name>
   <name>
    <surname>Presas-Rodríguez</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Crespo-Cuevas</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Canento</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Lozano-Sánchez</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Massuet-Vilamajó</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ramo-Tello</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen</article-title>
  <source>Neurodegener. Dis. Manag.</source>
  <year>2015</year>
  <volume>5</volume>
  <fpage>399</fpage>
  <lpage>402</lpage>
  <pub-id pub-id-type="doi">10.2217/nmt.15.42</pub-id>
  <pub-id pub-id-type="pmid">26517599</pub-id>
 </element-citation>
</ref>
